Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Gilbert

Showing results (171-180 of 453) with videos related to

Pageof 46
Sort By:
Cancers|July 2, 2021
Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient SurvivalJulianie De La Cruz Minyety, Dorela D Shuboni-Mulligan, Nicole Briceno, et al.
Biosensors|January 2, 2019
Detection of Metabolic Changes Induced via Drug Treatments in Live Cancer Cells and Tissue Using Raman Imaging MicroscopyMioara Larion, Tyrone Dowdy, Victor Ruiz-Rodado, et al.
Neuro-Oncology|June 12, 2016
Sleep-wake disturbance in patients with brain tumorsTerri S Armstrong, Marcia Y Shade, Ghislain Breton, et al.
Pharmacology & Therapeutics|September 7, 2016
The functional interplay between systemic cancer and the hematopoietic stem cell nicheAmber J Giles, Christopher D Chien, Caitlin M Reid, et al.
Cancer|March 15, 2012
Congruence of primary brain tumor patient and caregiver symptom reportTerri S Armstrong, Jeffrey S Wefel, Ibrahima Gning, et al.
Journal of Neuro-Oncology|June 19, 2019
Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECTGabrielle Truitt, Haley Gittleman, Rebecca Leece, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanismsArnab Chakravarti, Michael G Erkkinen, Ulf Nestler, et al.
Neuro-Oncology Practice|March 20, 2025
Neighborhood disadvantage is associated with treatment access outcomes and survival among individuals with a primary brain tumorMacy L Stockdill, Jacqueline B Vo, Orieta Celiku, et al.
Journal of Neuro-Oncology|December 29, 2011
Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitorsSamuel A Goldlust, Robert Cavaliere, Herbert B Newton, et al.
Journal of Neuro-Oncology|May 8, 2014
Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastomaMohamed A Hamza, Jacob J Mandel, Charles A Conrad, et al.
Pageof 46

Showing results (171-180 of 453) with videos related to

Sort By:
Pageof 46
Cancers|July 2, 2021
Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient SurvivalJulianie De La Cruz Minyety, Dorela D Shuboni-Mulligan, Nicole Briceno, et al.
Biosensors|January 2, 2019
Detection of Metabolic Changes Induced via Drug Treatments in Live Cancer Cells and Tissue Using Raman Imaging MicroscopyMioara Larion, Tyrone Dowdy, Victor Ruiz-Rodado, et al.
Neuro-Oncology|June 12, 2016
Sleep-wake disturbance in patients with brain tumorsTerri S Armstrong, Marcia Y Shade, Ghislain Breton, et al.
Pharmacology & Therapeutics|September 7, 2016
The functional interplay between systemic cancer and the hematopoietic stem cell nicheAmber J Giles, Christopher D Chien, Caitlin M Reid, et al.
Cancer|March 15, 2012
Congruence of primary brain tumor patient and caregiver symptom reportTerri S Armstrong, Jeffrey S Wefel, Ibrahima Gning, et al.
Journal of Neuro-Oncology|June 19, 2019
Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECTGabrielle Truitt, Haley Gittleman, Rebecca Leece, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanismsArnab Chakravarti, Michael G Erkkinen, Ulf Nestler, et al.
Neuro-Oncology Practice|March 20, 2025
Neighborhood disadvantage is associated with treatment access outcomes and survival among individuals with a primary brain tumorMacy L Stockdill, Jacqueline B Vo, Orieta Celiku, et al.
Journal of Neuro-Oncology|December 29, 2011
Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitorsSamuel A Goldlust, Robert Cavaliere, Herbert B Newton, et al.
Journal of Neuro-Oncology|May 8, 2014
Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastomaMohamed A Hamza, Jacob J Mandel, Charles A Conrad, et al.
Pageof 46